B. Braun Medical’s Infusion Safety Analysis Service, which is designed to ensure meaningful use of infusion data to promote best practices and improve outcomes, has identified opportunities to reduce alerts and improve drug library use. The findings have been published in two peer reviewed sources.

A retrospective analysis of drug library alert data of more than 4 million therapies and 50 hospitals showed a low incidence of alerts (1%) and corrections (0.1%) when the drug library was used, indicating a low incidence of programming error, which may help to minimize alert fatigue.

The analysis, which used B. Braun’s proprietary DoseTrac Infusion Management Software, also identified the top therapies and practices that cause alerts. These findings were delivered in a poster presentation. The Infusion Safety Analysis Service also helped to reveal the top infusions and key practices contributing to smart pump workarounds and noncompliance.

“Eliminating clinical workarounds through improved smart pump drug library use” concluded that in order to achieve up to 100% drug library compliance, the following three things should occur: 1) multi-disciplinary collaboration, 2) analysis of programming sequence surrounding alerts and the ability to view practice in real-time, and 3) routine review of data and measurement of outcomes. The publication appeared in the Association for the Advancement of Medical Instrumentation (AAMI) Horizons Journal.

“The overall clinical impact of using our Infusion Safety Analysis Service with targeted drug library adjustments and education has helped hospitals achieve up to 100% drug library use, up to 99% reduction in alerts, and a significant reduction in infusion related medication errors,” said Rachel Vitoux, director of sales, clinical services at B. Braun.

B. Braun showcased DoseTrac’s reporting software and Analysis Service at this year’s American Association of Critical-Care Nurses National Teaching Institute & Critical Care Exposition.

B. Braun Medical
bbraunusa.com